Cargando…

Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes: A pilot, randomized, controlled study

OBJECTIVE: This study investigated the safety and efficacy of sitagliptin (Januvia) for the inpatient management of type 2 diabetes (T2D) in general medicine and surgery patients. RESEARCH DESIGN AND METHODS: In this pilot, multicenter, open-label, randomized study, patients (n = 90) with a known hi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umpierrez, Guillermo E., Gianchandani, Roma, Smiley, Dawn, Jacobs, Sol, Wesorick, David H., Newton, Christopher, Farrokhi, Farnoosh, Peng, Limin, Reyes, David, Lathkar-Pradhan, Sangeeta, Pasquel, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816910/ https://www.ncbi.nlm.nih.gov/pubmed/23877988 http://dx.doi.org/10.2337/dc13-0277

Ejemplares similares

Randomized Controlled Trial of Insulin Supplementation for Correction of Bedtime Hyperglycemia in Hospitalized Patients With Type 2 Diabetes
por: Vellanki, Priyathama, et al.
Publicado: (2015)

Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
por: Umpierrez, Guillermo E., et al.
Publicado: (2011)

Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery
por: Cardona, Saumeth, et al.
Publicado: (2019)

Management of Inpatient Hyperglycemia and Diabetes in Older Adults
por: Umpierrez, Guillermo E., et al.
Publicado: (2017)

Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial
por: Umpierrez, Guillermo, et al.
Publicado: (2015)

A Comparison of Inpatient Cost Per Day in General Surgery Patients with Type 2 Diabetes Treated with Basal-Bolus versus Sliding Scale Insulin Regimens
por: Phillips, Victoria L., et al.
Publicado: (2017)

A randomized controlled trial comparing treatment with oral agents and basal insulin in elderly patients with type 2 diabetes in long-term care facilities
por: Pasquel, Francisco J, et al.
Publicado: (2015)

Hyperglycemia During Total Parenteral Nutrition: An important marker of poor outcome and mortality in hospitalized patients
por: Pasquel, Francisco J., et al.
Publicado: (2010)

Chronic Obstructive Pulmonary Disease: Inpatient Management
por: Harte, Brian J., et al.
Publicado: (2013)

Recurrent Diabetic Ketoacidosis in Inner-City Minority Patients: Behavioral, socioeconomic, and psychosocial factors
por: Randall, Lori, et al.
Publicado: (2011)

Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes: Basal Plus Trial
por: Umpierrez, Guillermo E., et al.
Publicado: (2013)

SAT138 “Zero”Ing On Hypoglycemia Caused By Hyperkalemia Treatments In The Inpatient Setting
por: Kim, Steve, et al.
Publicado: (2023)

Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis
por: Klonoff, David C., et al.
Publicado: (2021)

Predictive Value of Admission Hemoglobin A(1c) on Inpatient Glycemic Control and Response to Insulin Therapy in Medicine and Surgery Patients With Type 2 Diabetes
por: Pasquel, Francisco J., et al.
Publicado: (2015)

SAT147 A Pharmacist Driven Active Surveillance Program To Reduce Hypoglycemic Recurrences In The Inpatient Setting
por: Kim, Steve, et al.
Publicado: (2023)

Lack of Lipotoxicity Effect on β-Cell Dysfunction in Ketosis-Prone Type 2 Diabetes
por: Umpierrez, Guillermo E., et al.
Publicado: (2010)

Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises
por: Vellanki, Priyathama, et al.
Publicado: (2020)

THU247 Characterizing Inpatient Cases Of DKA Precipitated By SGLT2 Inhibitor Use
por: Aslamy, Arianne, et al.
Publicado: (2023)

Insulin Analogs Versus Human Insulin in the Treatment of Patients With Diabetic Ketoacidosis: A randomized controlled trial
por: Umpierrez, Guillermo E., et al.
Publicado: (2009)

Impact of obesity on hospital complications and mortality in hospitalized patients with hyperglycemia and diabetes
por: Alexopoulos, Anastasia-Stefania, et al.
Publicado: (2016)

Effects of Intravenous Glucose Load on Insulin Secretion in Patients With Ketosis-Prone Diabetes During Near-Normoglycemia Remission
por: Gosmanov, Aidar R., et al.
Publicado: (2010)

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)
por: Nauck, Michael, et al.
Publicado: (2014)

A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine
por: Mathieu, Chantal, et al.
Publicado: (2015)

Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery
por: Frisch, Anna, et al.
Publicado: (2010)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

Gaps in our knowledge of managing inpatient dysglycaemia and diabetes in non‐critically ill adults: A call for further research
por: Dhatariya, Ketan K., et al.
Publicado: (2022)

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5). Diabetes Care 2014;37:2149–2158
por: Nauck, Michael, et al.
Publicado: (2015)

1-h Glucose During Oral Glucose Tolerance Test Predicts Hyperglycemia Relapse-Free Survival in Obese Black Patients With Hyperglycemic Crises
por: Jagannathan, Ram, et al.
Publicado: (2022)

Estándares de calidad para cuidados de enfermería
por: Wesorick, Bonnie
Publicado: (1993)

Safety and Efficacy of Inpatient Diabetes Management with Non-insulin Agents: an Overview of International Practices
por: Galindo, Rodolfo J., et al.
Publicado: (2022)

Sitagliptin: Is It Effective in Routine Clinical Practice?
por: Mohan Dallumal, Rita, et al.
Publicado: (2015)

Sitagliptin-induced hemolysis
por: Bekur, Ragini, et al.
Publicado: (2010)

Sitagliptin-Associated Angioedema
por: Gosmanov, Aidar R., et al.
Publicado: (2012)

Statistical Comments on “Salivary Iron (Fe) Ion Levels, Serum Markers of Anemia and Caries Activity in Pregnant Women”
por: Farrokhi, Mehrdad, et al.
Publicado: (2017)

Adjunctive Sitagliptin Therapy in Postoperative Cardiac Surgery Patients: A Pilot Study
por: Brackbill, Marcia L., et al.
Publicado: (2012)

The journey continues in Clinical Diabetes and Endocrinology
por: Barkan, Ariel, et al.
Publicado: (2018)

Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
por: Cho, Yong Kyun
Publicado: (2018)

Effect of sitagliptin on proteinuria in patients with type 2 diabetes – A renoprotective effect of sitagliptin
por: Narimani, Rouhollah, et al.
Publicado: (2021)

Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19
por: Pasquel, Francisco J., et al.
Publicado: (2021)

PSUN191 Hospital Outcomes of Intensive and Standard Inpatient Glycemic Targets: A Propensity Scored-Matched Post Hoc Analysis of Insulin-Treated Patients with Type 2 Diabetes
por: Fafyman, Maya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j91mj837hmvvpvg16e4qnidjtl